Medicare Enrolled
Dr. David Lehman, M.D.
Rheumatology · Sacramento, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lehman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lehman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lehman
Dr. David Lehman is a rheumatology specialist in Sacramento, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lehman performed 8,128 Medicare services across 1,328 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lehman received a total of $20,006 from 61 pharmaceutical and/or device companies across 693 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lehman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in CA
$20,006 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,128
Medicare services
Top 24% in CA for rheumatology
1,328
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~428 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,520 | $18 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
703 | $65 | $125 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
527 | $60 | $145 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
287 | $125 | $185 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
229 | $138 | $175 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
198 | $1 | $8 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $12 | $50 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
105 | $44 | $140 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
90 | $146 | $225 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
90 | $33 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
86 | $76 | $94 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
50 | $8 | $150 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
31 | $12 | $65 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
25 | $33 | $50 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
20 | $32 | $80 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
17 | $224 | $280 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
16 | $90 | $92 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
14 | $163 | $278 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
13 | $51 | $188 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,006
Total received (2018-2024)
Avg $2,858/year across 7 years
Top 18% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
693
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,921 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,117
2023
$3,526
2022
$2,558
2021
$2,622
2020
$1,322
2019
$3,324
2018
$3,538
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$557
Novartis Pharmaceuticals Corporation
$289
GlaxoSmithKline, LLC.
$266
Boehringer Ingelheim Pharmaceuticals, Inc.
$259
Amgen Inc.
$237
AstraZeneca Pharmaceuticals LP
$209
Bayer Healthcare Pharmaceuticals Inc.
$199
Corcept Therapeutics
$186
ABBVIE INC.
$179
Alexion Pharmaceuticals, Inc.
$142
Radius Health, Inc.
$118
Lilly USA, LLC
$117
SANOFI-AVENTIS U.S. LLC
$106
PFIZER INC.
$105
Mallinckrodt Hospital Products Inc.
$47
Neurocrine Biosciences, Inc.
$30
Lexicon Pharmaceuticals, Inc.
$25
Collegium Pharmaceutical, Inc.
$21
Sumitomo Pharma America, Inc.
$14
IDORSIA PHARMACEUTICALS US INC
$13
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,371
GlaxoSmithKline, LLC.
$1,855
Janssen Pharmaceuticals, Inc
$1,849
Janssen Biotech, Inc.
$1,408
AstraZeneca Pharmaceuticals LP
$1,382
Lilly USA, LLC
$1,217
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,116
Novartis Pharmaceuticals Corporation
$876
PFIZER INC.
$845
ABBVIE INC.
$833
E.R. Squibb & Sons, L.L.C.
$654
AbbVie, Inc.
$405
Bayer Healthcare Pharmaceuticals Inc.
$355
Genentech USA, Inc.
$294
Mallinckrodt Hospital Products Inc.
$293
Bayer HealthCare Pharmaceuticals Inc.
$287
Novo Nordisk Inc
$274
Alexion Pharmaceuticals, Inc.
$260
SANOFI-AVENTIS U.S. LLC
$240
AbbVie Inc.
$228
Corcept Therapeutics
$186
Merck Sharp & Dohme Corporation
$184
GENZYME CORPORATION
$184
Kowa Pharmaceuticals America, Inc.
$144
Radius Health, Inc.
$141
Regeneron Healthcare Solutions, Inc.
$123
Merck Sharp & Dohme LLC
$122
Alcresta Therapeutics, Inc.
$122
Takeda Pharmaceuticals U.S.A., Inc.
$120
Alkermes, Inc.
$119
Lundbeck LLC
$115
Janssen Scientific Affairs, LLC
$96
Pfizer Inc.
$94
Celgene Corporation
$93
Horizon Pharma plc
$85
Collegium Pharmaceutical, Inc.
$81
Pacira Pharmaceuticals Incorporated
$75
Biohaven Pharmaceutical Holding Company Ltd.
$75
Mallinckrodt LLC
$73
Aurinia Pharma U.S., Inc.
$69
UCB, Inc.
$65
Lexicon Pharmaceuticals, Inc.
$64
Kiniksa Pharmaceuticals, Ltd.
$59
Neurocrine Biosciences, Inc.
$49
BioDelivery Sciences International, Inc.
$48
Biogen, Inc.
$43
Horizon Therapeutics plc
$39
Mallinckrodt Enterprises LLC
$39
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$36
Sunovion Pharmaceuticals Inc.
$34
IDORSIA PHARMACEUTICALS US INC
$27
Keryx Biopharmaceuticals, Inc.
$25
Abbott Laboratories
$21
EISAI INC.
$19
Exact Sciences Corporation
$16
Eisai Inc.
$16
Almatica Pharma LLC
$16
ARBOR PHARMACEUTICALS, INC.
$14
Sumitomo Pharma America, Inc.
$14
Actelion Pharmaceuticals US, Inc.
$13
AKEBIA THERAPEUTICS INC
$4
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · ANORO · ANORO ELLIPTA · AREXVY · AURYXIA · Actemra · Aimovig · Arcalyst · Auryxia · BELBUCA · BELSOMRA · BENLYSTA · BEVESPI AEROSPHERE · BREO · BRILINTA · BYDUREON · Belbuca · CAMZYOS · CHANTIX · COSENTYX · CREON · CardioMEMS HF System · Cimzia · Cologuard Collection Kit · DIFICID · DUPIXENT · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EXPAREL · Edarbi · Enbrel · FARXIGA · FORTEO · GEMTESA · GRALISE · HUMIRA · Humira · ILARIS · INFLECTRA · INGREZZA · INVOKANA · Inpefa · JANUVIA · JARDIANCE · KEVZARA · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LUPKYNIS · LYBALVI · LYRICA · Livalo · MOUNJARO · NORTHERA · NUCALA · NURTEC ODT · OFEV · OPSUMIT · ORENCIA · Ongentys · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · Prolia · QUVIVIQ · RELIZORB · REMICADE · REYVOW · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Repatha · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPIRIVA RESPIMAT · STRENSIQ · TALTZ · TAVNEOS · TOUJEO · TRELEGY ELLIPTA · TREMFYA · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Trintellix · Tymlos · UBRELVY · VERQUVO · VRAYLAR · Victoza · XARELTO · XELJANZ · XTAMPZA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
49
Per 100K population
3.1
County median income
$88,724
Nearest hospital
MERCY GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lehman is a mixed practice specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lehman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lehman performed 5,520 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lehman receive payments from pharmaceutical companies?
Yes. Dr. Lehman received a total of $20,006 from 61 companies across 693 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lehman's costs compare to other rheumatologists in Sacramento?
Dr. Lehman's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lehman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Sacramento
Browse rheumatologists in Sacramento ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology